Stock data
IDEAYA Biosciences, Inc. (IDYA)
IDEAYA Biosciences, Inc. (IDYA) reported revenue of US$218.71M and net income of -US$113.70M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$218.71M | — | -US$159.31M | -US$113.70M | — |
| 2024 | US$7.00M | — | -US$326.98M | -US$274.48M | — |
| 2023 | US$23.39M | — | -US$134.43M | -US$112.96M | — |
| 2022 | US$50.93M | — | -US$62.50M | -US$58.66M | — |
| 2021 | US$27.94M | — | -US$50.27M | -US$49.76M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$8.86M | -US$112.45M | — |
| 2026-03-31 | US$6.56M | -US$98.54M | — |
| 2025-09-30 | US$207.83M | US$119.24M | — |
| 2025-06-30 | — | -US$77.49M | — |
| 2025-03-31 | — | -US$72.18M | — |
| 2024-12-31 | US$7.00M | -US$130.31M | — |
| 2024-09-30 | US$0.00M | -US$51.82M | — |
| 2024-06-30 | US$0.00M | -US$52.77M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.